Literature DB >> 29102956

Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study.

Uyen-Sa D T Nguyen1,2, Yuqing Zhang2,3, Na Lu2,3, Qiong Louie-Gao2, Jingbo Niu2,4, Alexis Ogdie5, Joel M Gelfand5, Michael P LaValley2, Maureen Dubreuil2, Jeffrey A Sparks6, Elizabeth W Karlson6, Hyon K Choi2,3.   

Abstract

OBJECTIVES: Smoking is associated with an increased risk of psoriatic arthritis (PsA) in the general population, but not among patients with psoriasis. We sought to clarify the possible methodological mechanisms behind this paradox.
METHODS: Using 1995-2015 data from The Health Improvement Network, we performed survival analysis to examine the association between smoking and incident PsA in the general population and among patients with psoriasis. We clarified the paradox using mediation analysis and conducted bias sensitivity analyses to evaluate the potential impact of index event bias and quantify its magnitude from uncontrolled/unmeasured confounders.
RESULTS: Of 6.65 million subjects without PsA at baseline, 225 213 participants had psoriasis and 7057 developed incident PsA. Smoking was associated with an increased risk of PsA in the general population (HR 1.27; 95% CI 1.19 to 1.36), but with a decreased risk among patients with psoriasis (HR 0.91; 95% CI 0.84 to 0.99). Mediation analysis showed that the effect of smoking on the risk of PsA was mediated almost entirely through its effect on psoriasis. Bias-sensitivity analyses indicated that even when the relation of uncontrolled confounders to either smoking or PsA was modest (both HRs=~1.5), it could reverse the biased effect of smoking among patients with psoriasis (HR=0.9).
CONCLUSIONS: In this large cohort representative of the UK general population, smoking was positively associated with PsA risk in the general population, but negatively associated among patients with psoriasis. Conditioning on a causal intermediate variable (psoriasis) may even reverse the association between smoking and PsA, potentially explaining the smoking paradox for the risk of PsA among patients with psoriasis. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  epidemiology; psoriatic arthritis; smoking

Mesh:

Year:  2017        PMID: 29102956      PMCID: PMC5978759          DOI: 10.1136/annrheumdis-2017-211625

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

Review 1.  Selection bias in rheumatic disease research.

Authors:  Hyon K Choi; Uyen-Sa Nguyen; Jingbo Niu; Goodarz Danaei; Yuqing Zhang
Journal:  Nat Rev Rheumatol       Date:  2014-04-01       Impact factor: 20.543

2.  Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases.

Authors:  Jasvinder A Singh; Aaron R Holmgren; Hollis Krug; Siamak Noorbaloochi
Journal:  Arthritis Rheum       Date:  2007-05-15

Review 3.  Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.

Authors:  Anne-Marie Tobin; Douglas J Veale; Oliver Fitzgerald; Sarah Rogers; Paul Collins; Donal O'Shea; Brian Kirby
Journal:  J Rheumatol       Date:  2010-05-15       Impact factor: 4.666

4.  Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research.

Authors:  James D Lewis; Rita Schinnar; Warren B Bilker; Xingmei Wang; Brian L Strom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-04       Impact factor: 2.890

5.  Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates.

Authors:  Betina T Blak; Mary Thompson; Hassy Dattani; Alison Bourke
Journal:  Inform Prim Care       Date:  2011

6.  Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network.

Authors:  Alexis Ogdie; Sara Alehashemi; Thorvardur Jon Love; Yihui Jiang; Kevin Haynes; Sean Hennessy; Hyon Choi; Joel M Gelfand
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-07-05       Impact factor: 2.890

7.  Use of antidepressants and risk of lung cancer.

Authors:  Sengwee Toh; Luis A García Rodríguez; Sonia Hernández-Díaz
Journal:  Cancer Causes Control       Date:  2007-08-08       Impact factor: 2.506

8.  Obesity and the risk of psoriatic arthritis: a population-based study.

Authors:  Thorvardur Jon Love; Yanyan Zhu; Yuqing Zhang; Lindsay Wall-Burns; Alexis Ogdie; Joel M Gelfand; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2012-05-14       Impact factor: 19.103

9.  The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.

Authors:  Shanu Kohli Kurd; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2008-11-20       Impact factor: 11.527

10.  Sensitivity Analysis Without Assumptions.

Authors:  Peng Ding; Tyler J VanderWeele
Journal:  Epidemiology       Date:  2016-05       Impact factor: 4.822

View more
  14 in total

Review 1.  Psoriatic arthritis from a mechanistic perspective.

Authors:  Georg Schett; Proton Rahman; Christopher Ritchlin; Iain B McInnes; Dirk Elewaut; Jose U Scher
Journal:  Nat Rev Rheumatol       Date:  2022-05-05       Impact factor: 20.543

Review 2.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

Review 3.  Psoriatic arthritis in Africa.

Authors:  Ajesh B Maharaj; Adewale Adebajo
Journal:  Clin Rheumatol       Date:  2021-06-28       Impact factor: 2.980

Review 4.  Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management.

Authors:  Francesco Caso; Marco Tasso; Maria Sole Chimenti; Luca Navarini; Carlo Perricone; Nicolò Girolimetto; Rosario Peluso; Antonio Del Puente; Antonella Afeltra; Roberto Perricone; Leonardo Punzi; Raffaele Scarpa; Luisa Costa
Journal:  Drugs Aging       Date:  2019-10       Impact factor: 3.923

Review 5.  Insights into the pathogenesis of psoriatic arthritis from genetic studies.

Authors:  Sara Rahmati; Quan Li; Proton Rahman; Vinod Chandran
Journal:  Semin Immunopathol       Date:  2021-03-12       Impact factor: 11.759

6.  Incidence of Psoriatic Arthritis in Patients with Skin Psoriasis and Associated Risk Factors: A Retrospective Population-based Cohort Study in Swedish Routine Clinical Care.

Authors:  Ingrid Lindberg; Mathias Lilja; Kirk Geale; Haijun Tian; Craig Richardson; Amie Scott; Amra Osmancevic
Journal:  Acta Derm Venereol       Date:  2020-11-18       Impact factor: 3.875

7.  Evaluation of concomitant peripheral arthritis in patients with recent onset axial spondyloarthritis: 5-year results from the DESIR cohort.

Authors:  Clementina López-Medina; Maxime Dougados; Adeline Ruyssen-Witrand; Anna Moltó
Journal:  Arthritis Res Ther       Date:  2019-06-06       Impact factor: 5.156

8.  Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.

Authors:  Allard R J V Vossen; Hessel H van der Zee; Errol P Prens
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

Review 9.  Chronic obstructive pulmonary disease and rheumatic diseases: A systematic review on a neglected comorbidity.

Authors:  Irini Gergianaki; Ioanna Tsiligianni
Journal:  J Comorb       Date:  2019-01-07

Review 10.  Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review.

Authors:  Michelle L M Mulder; Tamara W van Hal; Mark H Wenink; Hans J P M Koenen; Frank H J van den Hoogen; Elke M G J de Jong; Juul M P A van den Reek; Johanna E Vriezekolk
Journal:  Arthritis Res Ther       Date:  2021-06-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.